The U.S. $749,999 contract, awarded through a highly competitive review process, supports early-stage therapeutic platform development for the Flexible and Strategic Therapeutics (FASTx) program of BARDA. This initiative aims to advance...
novel unconjugated antisense oligonucleotide (ASO) developed within AusperBio's proprietary Med-Oligo™ ASO technology platform, was designed to treat chronic hepatitis B for a functional cure. Its compelling preclinical data was highlighted at the...
immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is also approved in the U.S., Japan, China, and South Korea. About BioArctic AB: BioArctic AB...
retinal treatments, and lays the groundwork for future advancements.” Susvimo provides continuous delivery of a customized formulation of ranibizumab via the Port Delivery Platform, while other currently approved treatments may require multiple eye...
and Phase Ib/II in combination with MSD's pembrolizumab PMC-309 + Pembrolizumab combo is in plan. For additional information about PharmAbcine, visit http://www.pharmabcine.com
and Japan, with AbbVie responsible for further global commercialization. FL is typically an indolent (or slow-growing) form of non-Hodgkin's lymphoma (NHL) that arises from B-lymphocytes and is the second most common form of NHL accounting for...
Pines Therapeutics and the Harvard CBR Institute for Biomedical Research, and is headquartered in La Jolla, CA. For more information, please visit www.calcimedica.com.
value of all four serotypes of dengue virus as well as Zika, Chikungunya, and Yellow Fever viruses. Hyundai Bioscience has formulated the multi-treatment antiviral into a tablet form to facilitate mass production and to make it convenient for...
for Soldier rations and micronutrient delivery, leveraging Smart Cups' cutting-edge printing technology for enhanced performance and nutrition in military settings. Smart Cups also announced an exclusive two-year deal with Compana Pet Brands, a...
Rigaku we are focused on supporting our clients with our global expertise and development of innovative solutions that perform optimally, mitigate new chemical threats, and are always reliable and cost effective. Understanding the austere...
overdose from high doses of potent synthetic opioids, compared to a 4 mg dose of IN naloxone. Model simulations were performed using a validated translational model1 developed by the Division of Applied Regulatory Science in the US Food and Drug...
enrollment later this year. About BioMarin: Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root...
rights for a range of MTF Biologics’ tissue technologies, including placental, dermal, and adipose tissues. The tissue forms covered in the agreement include Amnioband® Membrane, Salera® Membrane, Salera® Mini-Membrane, Allopatch® Pliable,...
and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO-8 Class 100,000 Cleanroom. For more information please visit, www.qosmedix.com.
patients. "Immorta Bio is a Scientific Longevity Company. In that regard we are developing two longevity therapeutics platforms: Cellular Rejuvenation and Senolytic Immunotherapy (SenoVax™)," said Dr. Boris Reznik, Chairman and CEO of Immorta Bio....
immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is approved in the U.S., Japan, China, and South Korea with the following indications: About...
Disease and Idiopathic Pulmonary Fibrosis. We do this by targeting biologically validated pathways – including Transforming Growth Factor β and Hepatocyte Growth Factor - and by applying specialized capabilities in organ-restricted small molecules...
its synthetic tissue scaffold candidates based on the revolutionary Microporous Annealed Particle (MAP) technology platform into clinical trials, and the addition of Mr. Richman will maximize the chance for success and value." Eric has a...
Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, announced the outcome of the U.S. Food and Drug Administration's ("FDA") Psychopharmacologic Drugs Advisory Committee ("PDAC"), which discussed the Company's new...
peptides, metabolites, and lipids. This workflow includes third-party software support via Thermo Scientific Ardia™ platform and high throughput liquid chromatography separation with the Thermo Scientific Vanquish™ Neo ultra-high performance liquid...
